To summarize the approved diagnostic radionuclides, we underline that, for the initial staging of PC with BR and/or progression, [18F]DCFPyL (piflufolastat) and [68Ga] Ga-PSMA-11 should be used preponderately in the clinical settings. The gene discussed is FOLH1; the disease is pachyonychia congenita.